Experts Debate and Discuss Therapeutic Strategies Using CDK4/6 Inhibitors Across Breast Cancer

Gain up-to-date insights and knowledge from experts on the therapeutic use of CDK4/6 inhibitors in breast cancer treatment through slides, podcasts, and webcasts.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation